Mon, 06 Feb 2012 05:56:25 -0800
GlaxoSmithKline Q4 net up at Rs 59 cr
GlaxoSmithKline Consumer Healthcare on Monday posted little over ten per cent growth in net profit at Rs 59 crore in the fourth quarter ending December 31. | Fri, 27 Jan 2012 03:34:46 -0800
James Murdoch to quit GSK board
LONDON (Reuters) - James Murdoch, facing scrutiny over his role in a phone hacking scandal at the News of the World tabloid, is to step down from the board of GlaxoSmithKline, Britain's biggest drugmaker said on Friday. "James Murdoch has decided to stand down from the board with effect from this year's AGM," GSK Chairman Christopher Gent said in a statement. Murdoch took the decision to focus ... | Fri, 03 Feb 2012 09:12:31 -0800
Kolaveri man to boost Sachin's energy
Take a celebrated cricketer, a familiar beverage he has endorsed for over 20 years, a social media phenomenon that rocked the country, and a flash mob — it has all the makings of another song going viral. | Mon, 06 Feb 2012 22:23:26 -0800
Boardroom battles hot up as top executives step down
This will be the second high-profile exit from the company in recent months after Arun Kapur, the former chief executive, quit late last year. | Mon, 06 Feb 2012 10:54:45 -0800
Viom chief quits as graft controversy snowballs
Subodh Bhargava, chairman of Viom Networks, has decided to quit, citing his “discomfort about the speed at which the business was growing”. | Mon, 30 Jan 2012 14:52:35 -0800
Pledge to eliminate 10 neglected tropical diseases by 2020
Neglected diseases like kalazar, filariasis, blinding trachoma, sleeping sickness and leprosy, which affect millions of Indians every year, have finally got the attention they deserve. | Thu, 19 Jan 2012 08:25:27 -0800
Doping: Journey of a sample at London 2012
LONDON (Reuters) - More than 6,000 urine and blood samples will be analysed during the London 2012 Olympics, and scientists say the task of getting them from athlete to laboratory and back to Games officials is a race that demands speed, skill and security. Athletes can be tested anytime and anywhere, whether they're in the official villages, in private residences and whether they're inside or ... |
|
|
|
Tue, 07 Feb 2012 15:41:58 GMT
| Tue, 07 Feb 2012 16:02:35 GMT
| Tue, 07 Feb 2012 20:36:01 GMT
| Wed, 08 Feb 2012 08:42:47 GMT
| Wed, 08 Feb 2012 22:18:57 GMT
| Wed, 08 Feb 2012 13:00:34 GMT
| Wed, 08 Feb 2012 16:37:16 GMT
|
ChemoCentryx IPO Up 12% After Cutting PriceWall Street JournalSince August 2006, it has been in a strategic alliance with GlaxoSmithKline that allows GlaxoSmithKline the option of exclusively licensing drug candidates covered by the collaboration for further development and commercialization.and more » |
|
|
|
